We are live on ! Find out more
HIM

Hillhouse Investment Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 7.29%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
-7.29%
3 Year Est. Return
+122.05%
5 Year Est. Return
+101.44%
10 Year Est. Return
AUM
$3.74B
AUM Growth
-$2.13B
Cap. Flow
-$1.74B
Cap. Flow %
-46.47%
Top 10 Hldgs %
76.73%
Holding
64
New
10
Increased
6
Reduced
11
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 43.05%
2 Consumer Discretionary 19.53%
3 Financials 11.05%
4 Communication Services 6.87%
5 Consumer Staples 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$32.8B
$942M 25.19%
5,472,259
JD icon
2
JD.com
JD
$44.6B
$553M 14.79%
21,212,125
ESGR
3
DELISTED
Enstar Group
ESGR
$364M 9.74%
1,747,840
CBPO
4
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$220M 5.88%
2,751,200
+2,132,809
+345% +$199M
WUBA
5
DELISTED
58.com Inc
WUBA
$194M 5.19%
2,638,675
-2,709,998
-51% -$187M
KYNB
6
Kyntra Bio
KYNB
$27.2M
$163M 4.36%
107,448
MDLZ icon
7
Mondelez International
MDLZ
$79.5B
$152M 4.05%
3,529,264
BPMC
8
DELISTED
Blueprint Medicines
BPMC
$112M 2.99%
1,430,949
SNAP icon
9
Snap
SNAP
$7.89B
$93.2M 2.49%
10,989,529
APLS
10
DELISTED
Apellis Pharmaceuticals
APLS
$77M 2.06%
4,328,289
BABA icon
11
Alibaba
BABA
$293B
$69.4M 1.85%
421,002
-6,087,436
-94% -$1.08B
MYOK
12
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$56M 1.5%
858,340
PDD icon
13
Pinduoduo
PDD
$126B
$55.8M 1.49%
+2,121,896
New +$45.8M
IQ icon
14
iQIYI
IQ
$1.23B
$53.6M 1.43%
1,979,107
-1,496,769
-43% -$44.6M
KANG
15
DELISTED
iKang Healthcare Group, Inc.
KANG
$52.9M 1.41%
2,922,834
TAL icon
16
TAL Education Group
TAL
$6.93B
$52M 1.39%
2,024,450
+1,100,517
+119% +$35.6M
LN
17
DELISTED
LINE Corporation
LN
$50.9M 1.36%
1,207,763
GTHX
18
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$49.6M 1.33%
949,431
+250,000
+36% +$13.6M
BEDU
19
DELISTED
Bright Scholar Education Holdings
BEDU
$49.4M 1.32%
996,449
-76,868
-7% -$4.23M
XLRN
20
DELISTED
Acceleron Pharma
XLRN
$46.6M 1.24%
813,600
+113,600
+16% +$5.58M
KNSA icon
21
Kiniksa Pharmaceuticals
KNSA
$5.8B
$35.4M 0.95%
1,388,888
-4,347,639
-76% -$84.5M
LOXO
22
DELISTED
Loxo Oncology, Inc
LOXO
$22.4M 0.6%
131,300
+50,000
+62% +$8.4M
MLCO icon
23
Melco Resorts & Entertainment
MLCO
$2.22B
$19.3M 0.52%
913,329
-4,405,334
-83% -$102M
BRK.A icon
24
Berkshire Hathaway Class A
BRK.A
$1.1T
$16.3M 0.44%
51
SOHU
25
Sohu.com
SOHU
$362M
$15.9M 0.43%
802,034

Similar funds

Hillhouse Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Hillhouse Investment Management held 64 positions worth $3.74B, down 36% from $5.87B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Hillhouse Investment Management withdrew a net $1.74B in Q3 2018, closing 14 positions and reducing 11 holdings. Its most notable exit was Electronic Arts, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Hillhouse Investment Management opened a new position in Pinduoduo worth $55.8M.

  • Hillhouse Investment Management's largest Q3 2018 buy was Pinduoduo: 2,121,896 shares worth $55.8M.
  • Hillhouse Investment Management added most to China Biologic Products Holdings, Inc. in Q3 2018, an estimated $199M increase.
  • Hillhouse Investment Management's biggest Q3 2018 reduction was Alibaba, cutting an estimated $1.08B.
  • Hillhouse Investment Management fully exited Electronic Arts in Q3 2018, selling an estimated $115M.
  • Hillhouse Investment Management's ten largest holdings make up 77% of its $3.74B portfolio in Q3 2018.
  • Hillhouse Investment Management opened 10 new positions and closed 14 in Q3 2018.
  • Hillhouse Investment Management's portfolio value fell 36% quarter-over-quarter to $3.74B.

Based on Hillhouse Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.